Juan Du

Juan Du has a diverse work experience spanning over several decades. Juan is currently the Chief Business Officer at Kangnuo Biopharmaceutical Technology (Shanghai) Co., Ltd since March 2021. Previously, they served as a Partner at Hongfeng Investment Management Company from July 2018 to February 2021. Before that, they held the position of Senior VP, COO at Crimson Biotech Co., Ltd from August 2017 to June 2020.

From 2012 to 2017, Juan Du worked at HUYA Bioscience International as the Director of Shanghai Office. In this role, they led a group of scientists in scouting and evaluating innovative drug opportunities and managed the daily business operations in East China.

Prior to that, Juan Du served as the Director of Pharmacology Department at the Changzhou SIMM Drug R&D Centre, Chinese Academy of Science Shanghai Institute of Materia Medica from June 2006 to March 2012. In this position, they were responsible for product development, project management, and team management.

Before their industry experience, Juan Du also worked as a Post-doctoral Research Assistant at the Division of Molecular Genetics, University of Glasgow from June 1999 to April 2003. Additionally, they gained clinical experience as a Clinical Visiting Scholar at Tokyo Woman's Medical University from April 1994 to June 1999 and as a Senior Resident at Nanjing Children's Hospital from August 1983 to April 1993.

Juan Du earned a Ph.D. in Medical Science from Tokyo Women's Medical University, studying from 1994 to 1999. Before that, they attended Dongnan University School of Medicine from 1985 to 1988, focusing on Pediatrics. Prior to that, they attended Nanjing Health College from 1980 to 1983, specializing in Maternal and Child Health Care. No degree information is available for their time at Dongnan University School of Medicine and Nanjing Health College.